MS Oncologie
Board
1 director, since incorporationDirector (not named in the articles)
appointed by deed of 28-08-2024
term without a fixed end
listed in the 2025 annual accounts, filed on 31-08-2026
Mandates through the years
1 name, the dashed line is todayDirector (not named in the articles)
Board
Mandates as a list
-
- Director (not named in the articles), from 26-08-2024 to date
Control
Founder
This company
MS Oncologie
Equity €32,686
Profit €28,752 in 2025
Capital
- Contribution
- €3,000
- Shares
- 100
- Contribution per share
- €30
- Equity per share
- €327 in 2025
- Source
- deed of 28-08-2024
Articles of association
deed of 28-08-2024 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- “Six années maximum renouvelable sauf décision contraire assemblée, totalité pouvoirs administration,faculté déléguer partie”
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Remplir article 8 alinéa 5 en toutes hypothèses”
Shareholders
At incorporation
deed of 28-08-2024 ↗
- 100 shares (100%) · €3,000 in cash